BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan Y, Wang L, Gao J, Ma J, Yu H, Zhang Y, Wang T, Han L. Multiomics Integrative Analysis for Discovering the Potential Mechanism of Dioscin against Hyperuricemia Mice. J Proteome Res 2021;20:645-60. [PMID: 33107303 DOI: 10.1021/acs.jproteome.0c00584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Zhang A, Wu F, Wang X. UPLC-G2Si-HDMS Untargeted Metabolomics for Identification of Yunnan Baiyao's Metabolic Target in Promoting Blood Circulation and Removing Blood Stasis. Molecules 2022;27:3208. [PMID: 35630682 DOI: 10.3390/molecules27103208] [Reference Citation Analysis]
2 Wang L, Huang S, Zhu T, Ge X, Pei C, Hong G, Han L. Metabolomic Study on Iohexol-Induced Nephrotoxicity in Rats Based on NMR and LC-MS Analyses. Chem Res Toxicol 2022. [PMID: 35081708 DOI: 10.1021/acs.chemrestox.1c00299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao ZA, Jiang Y, Chen YY, Wu T, Lan QS, Li YM, Li L, Yang Y, Lin CT, Cao Y, Zhou PZ, Guo JY, Tian YX, Pang JX. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia. Acta Pharmacol Sin 2022;43:121-32. [PMID: 33767379 DOI: 10.1038/s41401-021-00640-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bandopadhyay S, Anand U, Gadekar VS, Jha NK, Gupta PK, Behl T, Kumar M, Radha, Shekhawat MS, Dey A. Dioscin: A review on pharmacological properties and therapeutic values. Biofactors 2021. [PMID: 34919768 DOI: 10.1002/biof.1815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Shan B, Chen T, Huang B, Liu Y, Chen J. Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia. J Ethnopharmacol 2021;281:114545. [PMID: 34419610 DOI: 10.1016/j.jep.2021.114545] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Chen Y, You R, Wang K, Wang Y. Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods. Evid Based Complement Alternat Med 2021;2021:5738900. [PMID: 34754317 DOI: 10.1155/2021/5738900] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 You L, Zheng F, Su C, Wang L, Li X, Chen Q, Kou J, Wang X, Wang Y, Wang Y, Mei S, Zhang B, Liu X, Xu G. Metabolome-wide association study of serum exogenous chemical residues in a cohort with 5 major chronic diseases. Environ Int 2021;158:106919. [PMID: 34634623 DOI: 10.1016/j.envint.2021.106919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
8 Shi B, Ding H, Wang L, Wang C, Tian X, Fu Z, Zhang L, Han L. Investigation on the stability in plant metabolomics with a special focus on freeze-thaw cycles: LC-MS and NMR analysis to Cassiae Semen (Cassia obtusifolia L.) seeds as a case study. J Pharm Biomed Anal 2021;204:114243. [PMID: 34273658 DOI: 10.1016/j.jpba.2021.114243] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Yang F, Shi W, Wang L, Qin N, Wang C, Guo Y, Xu G, Fang J, Yu X, Ma Q. Lipidomics study of the therapeutic mechanism of Plantaginis Semen in potassium oxonate-induced hyperuricemia rat. BMC Complement Med Ther 2021;21:175. [PMID: 34172058 DOI: 10.1186/s12906-021-03350-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]